A Phase Ib Study of Alpelisib (BYL719), a PI3K -specific Inhibitor, with Letrozole in ER+/HER2-Negative Metastatic Breast Cancer
Mayer, I. A., Abramson, V., Formisano, L., Balko, J. M., Estrada, M. V., Sanders, M., Juric, D., Solit, D., Berger, M. F., Won, H., Li, Y., Cantley, L. C., Winer, E. P., Arteaga, C. L.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-16-0134
Date:
April, 2016
File:
PDF, 2.54 MB
english, 2016
File converter
More search results
More benefits 
